-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VTisxcSJA7MaFWCPlU7TO5CZQnveNM/sOc2PZgAFWQ2m4/VkajxDeLs52RLbe3bo kV+cXE4P7vzTm4cERVriHQ== 0001140361-10-006181.txt : 20100212 0001140361-10-006181.hdr.sgml : 20100212 20100212171541 ACCESSION NUMBER: 0001140361-10-006181 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091231 FILED AS OF DATE: 20100212 DATE AS OF CHANGE: 20100212 EFFECTIVENESS DATE: 20100212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICAHN CAPITAL LP CENTRAL INDEX KEY: 0001412093 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12848 FILM NUMBER: 10600984 BUSINESS ADDRESS: STREET 1: 445 HAMILTON AVENUE STREET 2: SUITE 1210 CITY: WHITE PLAINS STATE: NY ZIP: 10601 BUSINESS PHONE: 914-614-7000 MAIL ADDRESS: STREET 1: 445 HAMILTON AVENUE STREET 2: SUITE 1210 CITY: WHITE PLAINS STATE: NY ZIP: 10601 FORMER COMPANY: FORMER CONFORMED NAME: ICAHN PARTNERS HOLDING LP DATE OF NAME CHANGE: 20070911 13F-HR 1 form13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: 12/31/2009 Check here if Amendment []; Amendment Number: ------- This Amendment (Check only one.): [] is a restatement. [] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: ICAHN CAPITAL LP Address: 445 HAMILTON AVENUE, SUITE 1210 WHITE PLAINS, NEW YORK 10601 Form 13F File Number: 028-12848 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Persons Signing this Report on Behalf of Reporting Manager: Name: IRENE MARCH Title: CHIEF FINANCIAL OFFICER Phone: 212-702-4300 Signature, Place, and Date of Signing: /s/ IRENE MARCH NEW YORK, NEW YORK 2/12/2010 - --------------------------------- --------------------------------- ---------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 20 Form 13F Information Table Value Total: $ 2,874,761 -------------- (In Thousands) List of Other Included Managers: Provide a numbered list of the name(s) and 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NONE
FORM 13F INFORMATION TABLE COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 - --------------------------------- -------------- --------- -------- -------------------- ---------- -------- ----------------------- VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - --------------------------------- -------------- --------- -------- ----------- --- ---- ---------- -------- ----------- ------ ---- ADVENTRX PHARMACEUTICALS INC COM 00764X103 1,211 3,459,459 SH SOLE N/A 3,459,459 0 0 AMYLIN PHARMACEUTICALS INC COM 32346108 184,063 12,971,328 SH SOLE N/A 12,971,328 0 0 BIOGEN IDEC INC COM 09062X103 688,021 12,860,205 SH SOLE N/A 12,860,205 0 0 BLOCKBUSTER INC CL A 93679108 7,051 10,523,840 SH SOLE N/A 10,523,840 0 0 BLOCKBUSTER INC CL B 93679207 2,627 4,452,905 SH SOLE N/A 4,452,905 0 0 CIT GROUP INC COM NEW 125581801 267,965 9,705,373 SH SOLE N/A 9,705,373 0 0 CYBERONICS INC COM 23251P102 43,087 2,107,972 SH SOLE N/A 2,107,972 0 0 ENZON PHARMACEUTICALS INC COM 293904108 29,662 2,816,861 SH SOLE N/A 2,816,861 0 0 EXELIXIS INC COM 30161Q104 17,372 2,357,110 SH SOLE N/A 2,357,110 0 0 FOREST LABS INC COM 345838106 38,953 1,213,120 SH SOLE N/A 1,213,120 0 0 GENZYME CORP COM 372917104 235,162 4,798,243 SH SOLE N/A 4,798,243 0 0 LIONS GATE ENTMNT CORP COM NEW 535919203 96,401 16,592,200 SH SOLE N/A 16,592,200 0 0 LIONS GATE ENTMNT CORP NOTE 2.938% 535919AF1 884 923,200 PRN SOLE N/A 923,200 0 0 LIONS GATE ENTMNT CORP NOTE 3.635% 535919AG9 325 343,200 PRN SOLE N/A 343,200 0 0 MOTOROLA INC COM 620076109 929,574 119,790,447 SH SOLE N/A 119,790,447 0 0 PROSHARES TR PSHS REAL 74347R552 198 26,400 SH SOLE N/A 26,400 0 0 ESTAT REGENERON PHARMACEUTICALS COM 75886F107 60,643 2,508,001 SH SOLE N/A 2,508,001 0 0 TAKE-TWO INTERACTIVE SOFTWARE INC COM 874054109 67,335 6,700,001 SH SOLE N/A 6,700,001 0 0 WENDYS ARBYS GROUP INC COM 950587105 3,018 643,590 SH SOLE N/A 643,590 0 0 YAHOO INC COM 984332106 201,209 11,991,000 SH SOLE N/A 11,991,000 0
-----END PRIVACY-ENHANCED MESSAGE-----